Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 19, 2023
Parent-reported health-related quality of life in pediatric childhood cancer survivors and factors associated with poor health-related quality of life in aftercareJana Winzig, Laura Inhestern, Verena Paul, et al.
British Journal of Haematology|April 19, 2013
Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndromeFranziska Meyr, Gabriele Escherich, Georg Mann, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96Cornelia Eckert, Arend von Stackelberg, Karl Seeger, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 5, 2013
Denosumab: a potential new and innovative treatment option for aneurysmal bone cystsTobias Lange, Christoph Stehling, Birgit Fröhlich, et al.
American Journal of Blood Research|May 16, 2013
Refinement of IKZF1 recombination hotspots in pediatric BCP-ALL patientsClaus Meyer, Udo Zur Stadt, Gabriele Escherich, et al.
Haematologica|August 11, 2018
Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study groupNaghmeh Niktoreh, Beate Lerius, Martin Zimmermann, et al.
Blood|February 12, 2013
Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescenceBettina R Bonn, Marius Rohde, Martin Zimmermann, et al.
Hemasphere|January 22, 2025
Secondary lesions and sensitivity to signaling inhibitors in iAMP21 acute lymphoblastic leukemiaFemke M Hormann, Anna Østergaard, Stijn van den Broek, et al.
Blood|February 23, 2024
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domainInge van Outersterp, Sarah K Tasian, Caitlin E J Reichert, et al.
Pediatric Blood & Cancer|February 27, 2018
Inflammatory myofibroblastic tumors-A retrospective analysis of the Cooperative Weichteilsarkom StudiengruppeStefanie Kube, Christian Vokuhl, Tobias Dantonello, et al.
Pageof 14